Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma

Fotemustine (FTM) is a common treatment option for glioblastoma patients refractory to temozolomide (TMZ). Although elderly patients represent a large component of glioblastoma population, the feasibility and the efficacy of second-line FTM are not available in those patients.We retrospectively anal...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Santoni, Matteo, Scoccianti, Silvia, Lolli, Ivan, Fabrini, Maria Grazia, Silvano, Giovanni, Detti, Beatrice, Perrone, Franco, Savio, Giuseppina, Iacovelli, Roberto, Burattini, Luciano, Berardi, Rossana, Cascinu, Stefano
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer US 2013
Témata:
Clinical Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3684712/
https://ncbi.nlm.nih.gov/pubmed/23564276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-013-1125-3
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky